about
Involvement of autophagy in ovarian cancer: a working hypothesisThe Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic CancersDNA methylation profiles in ovarian cancer: implication in diagnosis and therapy (Review)Ovarian cancer stem cells: are they real and why are they important?NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.Investigation of the expression patterns and correlation of DNA methyltransferases and class I histone deacetylases in ovarian cancer tissues.Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer.Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications.Biomarkers for early detection of ovarian cancer.Epigenetic silencing of the LDOC1 tumor suppressor gene in ovarian cancer cells.The plant extract of Pao pereira potentiates carboplatin effects against ovarian cancer.Cell senescence culturing methods.MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane.Risk assessment for epithelial ovarian cancer: proposing a new approach to a deadly problem.Research Priorities for Endometriosis.
P2860
Q21198790-6E474454-DC74-437D-95F3-B4AC406ECCBAQ28551531-D8005220-9654-479C-B03F-048BEF1E452DQ33799002-52F14C23-88E6-4470-A04C-835347692495Q35047699-4FD43DFE-F2C5-41BB-AF35-5BCA4BBCA8DDQ36396570-EB5C0CD3-C375-4145-8D3A-909741DDFD61Q36611841-855A1C09-EF67-4564-BD1E-C3B94EF9D45FQ37420213-5DAA0AB5-60B4-4697-9F1E-1FAEECDC23A0Q37502083-387E03A7-A186-4239-B55D-0B7568F9A7F0Q37606205-6D8A7098-6705-47A7-8FEE-6224D9C435B5Q38087982-A4DA1F93-1C7E-4B75-A4AE-7C57D060BBF0Q39022355-067CEFE4-CB62-444F-A493-A602B4AEA356Q39096454-9198EE0C-8996-4155-9666-18EE9062DF9EQ39113248-7752741B-0F79-4EDC-8E49-E72EBAFBA86BQ39210882-49A50F9E-FBCC-4A8F-A3B4-2AA42C8AA67FQ41610999-F59F6665-DFBE-4382-B7B3-EED8222396D7Q44306217-41A436FC-1641-4EDA-9005-E451E98539B8Q46565764-08B467A3-75D9-4833-B925-EF5EEC35C1B0
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epigenomics of ovarian cancer and its chemoprevention.
@ast
Epigenomics of ovarian cancer and its chemoprevention.
@en
type
label
Epigenomics of ovarian cancer and its chemoprevention.
@ast
Epigenomics of ovarian cancer and its chemoprevention.
@en
prefLabel
Epigenomics of ovarian cancer and its chemoprevention.
@ast
Epigenomics of ovarian cancer and its chemoprevention.
@en
P2860
P356
P1476
Epigenomics of ovarian cancer and its chemoprevention.
@en
P2093
Tabitha M Hardy
Trygve O Tollefsbol
P2860
P356
10.3389/FGENE.2011.00067
P50
P577
2011-10-04T00:00:00Z